Chugai Pharmaceutical Co. said Monday its consolidated pretax profits increased 10.2 percent during the first half of the business year to 18.85 billion yen.
These profits were generated on a 6.2 percent rise in group sales, which came in at 108.22 billion yen.
Its consolidated net profits, however, shrank 11.4 percent in the April-September period to 9.14 billion yen, primarily due to appraisal losses on stockholdings sustained under the nation's new accounting rules.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.